EUVIMEDEUVIMED entdecken
Crossref

Y-90 Radioembolization in Hepatocellular Carcinoma: Expanding the Role of Interventional Oncology in Downstaging and Bridging to Liver Transplantation

Linzi Arndt Webster, Ariana Mills, Deepak Iyer, Kirema García-Reyes

Digestive Disease Interventions · 08.04.2026

DOI: 10.1055/a-2827-0637 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Digestive Disease Interventions, erschienen am 08.04.2026. Verfasst von Linzi Arndt Webster und 3 weiteren Autor:innen.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

AbstractTransarterial radioembolization (TARE) with Yttrium-90 (Y-90) is increasingly utilized as a first-line modality in the management of hepatocellular carcinoma, offering effective local tumor control with favorable toxicity profiles. While traditionally viewed as palliative, accumulating evidence supports its use as curative intent therapy and in bridging or downstaging patients to transplant. This review explores the expanding role of Y-90 in downstaging patients beyond transplant criteria and in bridging those already eligible. We highlight the outcomes from pivotal studies, including LEGACY and DOSISPHERE-01, which demonstrate high rates of sustained tumor response, low transplant list dropout, and excellent posttransplant survival—especially when TARE is delivered segmentally and with personalized dosimetry. Y-90's ability to preserve hepatic function and achieve superior local control in larger tumors makes it particularly well-suited to the transplant population. We compare Y-90 with transarterial chemoembolization, addressing key distinctions in efficacy, durability, and tolerability. Practical considerations—including patient selection, treatment planning, transplant timing, and multidisciplinary coordination—are reviewed. Finally, we discuss future directions, including the role of Y-90 in combination with immunotherapy and ongoing prospective transplant-centered trials.

Zitieren

APA

Webster, L. A., Mills, A., Iyer, D., & García-Reyes, K. (2026). Y-90 Radioembolization in Hepatocellular Carcinoma: Expanding the Role of Interventional Oncology in Downstaging and Bridging to Liver Transplantation. Digestive Disease Interventions. https://doi.org/10.1055/a-2827-0637

Vancouver

Webster LA, Mills A, Iyer D, García-Reyes K. Y-90 Radioembolization in Hepatocellular Carcinoma: Expanding the Role of Interventional Oncology in Downstaging and Bridging to Liver Transplantation. Digestive Disease Interventions. 2026. doi:10.1055/a-2827-0637

BibTeX
@article{Webster2026,
  author = {Webster, Linzi Arndt and Mills, Ariana and Iyer, Deepak and García-Reyes, Kirema},
  title = {Y-90 Radioembolization in Hepatocellular Carcinoma: Expanding the Role of Interventional Oncology in Downstaging and Bridging to Liver Transplantation},
  journal = {Digestive Disease Interventions},
  year = {2026},
  doi = {10.1055/a-2827-0637}
}
Kostenlos starten →